Walvax Biotechnology (300142.SZ): Freeze-dried herpes simplex virus mRNA vaccine approved for clinical trial.
Watson Biology (300142.SZ) announced that its subsidiaries, Beijing Watson Innovative Biotechnology Co., Ltd., Yunnan Vaccine Laboratory Co., Ltd., Yuxi Watson Biotechnology Co., Ltd., in collaboration with Fudan University and Shanghai Lanque Biomedical Co., Ltd. (referred to as "Lanque Biomedical"), have jointly developed and applied for clinical trials of a freeze-dried herpes zoster virus mRNA vaccine, and recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. After review, the freeze-dried herpes zoster virus mRNA vaccine accepted on September 18, 2025 meets the relevant requirements for drug registration and is approved to conduct clinical trials for the prevention of herpes zoster.
Walvax Biotechnology (300142.SZ) announced that its subsidiaries Beijing Watson Innovative Biotechnology Co., Ltd., Yunnan Vaccine Laboratory Co., Ltd., and Yuxi Walvax Biotechnology Technology Co., Ltd. have jointly developed a freeze-dried herpes zoster virus mRNA vaccine with Fudan University and Shanghai Lanque Biomedical Technology Co., Ltd. (referred to as "Lanque Biomedical"). The vaccine recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. After review, the freeze-dried herpes zoster virus mRNA vaccine, which was accepted for review on September 18, 2025, meets the relevant requirements for drug registration and is approved to conduct clinical trials for the prevention of herpes zoster.
Related Articles
CH ENERGY ENG (03996) overseas investment project receives financing support.
On December 12, EDIANYUN (02416) spent approximately HK$155,300 to repurchase 74,500 shares.
Yum China (09987): Wei Zhe appointed as member of the Nomination and Governance Committee of the Board of Directors.
CH ENERGY ENG (03996) overseas investment project receives financing support.
On December 12, EDIANYUN (02416) spent approximately HK$155,300 to repurchase 74,500 shares.
Yum China (09987): Wei Zhe appointed as member of the Nomination and Governance Committee of the Board of Directors.
